Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality
Santosh Karnewar(University of Virginia), Gary K. Owens(University of Virginia)
Cited by 2
Related Papers
Vascular Smooth Muscle Cells in Atherosclerosis
|Circulation Research|2016|2.1k
Recent insights into the cellular biology of atherosclerosis
|The Journal of Cell Biology|2015|1k
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
|Nature Medicine|2018|254